Literature DB >> 11217249

Ischaemic optic neuropathy.

S S Hayreh1.   

Abstract

Ischaemic optic neuropathy is of two types: anterior (AION) and posterior (PION), the first involving the optic nerve head (ONH) and the second, the rest of the optic nerve. Pathogenetically AION and PION are very different diseases. AION represents an acute ischaemic disorder of the ONH supplied by the posterior ciliary artery (PCA), while PION has no specific location in the posterior part of the optic nerve and does not represent an ischaemic disorder of any definite artery. The most important step towards a logical understanding of the underlying causes, clinical features, pathogenesis and rational management of AION, is to understand the basic scientific issues involved; these are discussed in some detail. AION clinically is of two types: (1) that due to giant cell arteritis (arteritic AION: A-AION) and (2) non-arteritic AION (NA-AION). NA-AION, the more common of the two, is one of the most prevalent and visually crippling diseases in the middle-aged and elderly, and is potentially bilateral. NA-AION is a multifactorial disease, with many risk factors collectively contributing to its development. Although there is no known treatment for NA-AION, reduction of risk factors is important in decreasing chances of involvement of the second eye and of further episodes. Our studies have suggested that nocturnal arterial hypotension is an important risk factor for the development and progression of NA-AION. The role of nocturnal arterial hypotension in the pathogenesis of NA-AION and management of nocturnal hypotension is discussed. Potent antihypertensive drugs, when used aggressively and/or given at bedtime, are emerging as an important risk factor for nocturnal hypotension, and there is some evidence that NA-AION may be occurring as an iatrogenic disease in some individuals. A-AION, by contrast, is an ocular emergency and requires immediate treatment with systemic corticosteroids to prevent further visual loss. The clinical parameters which help to differentiate the two types of AION, and their respective management are discussed.

Entities:  

Mesh:

Year:  2000        PMID: 11217249

Source DB:  PubMed          Journal:  Indian J Ophthalmol        ISSN: 0301-4738            Impact factor:   1.848


  19 in total

1.  Efficacy and tolerability of 0.2% brimonidine tartrate for the treatment of acute non-arteritic anterior ischemic optic neuropathy (NAION): a 3-month, double-masked, randomised, placebo-controlled trial.

Authors:  Barbara Wilhelm; Holger Lüdtke; Helmut Wilhelm
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-09-08       Impact factor: 3.117

2.  Anterior ischemic optical neuropathy in children on chronic peritoneal dialysis: report of 7 cases.

Authors:  Giacomo Di Zazzo; Isabella Guzzo; Lara De Galasso; Michele Fortunato; Giovanna Leozappa; Licia Peruzzi; Enrico Vidal; Ciro Corrado; Enrico Verrina; Stefano Picca; Francesco Emma
Journal:  Perit Dial Int       Date:  2015 Mar-Apr       Impact factor: 1.756

3.  Bilateral posterior ischaemic optic neuropathy after severe diabetic ketoacidosis, cardiopulmonary resuscitation and respiratory failure.

Authors:  Christina Doris Wirth; Christoph Leitner; Martin Perrig
Journal:  BMJ Case Rep       Date:  2013-02-14

4.  Nonarteritic anterior ischemic optic neuropathy treated with intravenous prostaglandin E1 and steroids.

Authors:  Robert D Steigerwalt; M Rosaria Cesarone; Gianni Belcaro; Antonella Pascarella; Mauro De Angelis; Sabrina Bacci
Journal:  Int J Angiol       Date:  2008

5.  Diffusion tensor imaging of the optic nerve in subacute anterior ischemic optic neuropathy at 3T.

Authors:  M-Y Wang; P-H Qi; D-P Shi
Journal:  AJNR Am J Neuroradiol       Date:  2011-06-23       Impact factor: 3.825

6.  Imageology of internal carotid artery siphon in non-arteritic anterior ischaemic optic neuropathy.

Authors:  Zhi-Yong Fu; Hong-Yang Li; Yan-Ling Wang
Journal:  Int J Ophthalmol       Date:  2020-12-18       Impact factor: 1.779

7.  [Quantification of fluorescein angiography in patients with non-arteritic anterior ischemic optic neuropathy].

Authors:  T Hirsch; A Remky; N Plange; M Kaup
Journal:  Ophthalmologe       Date:  2011-08       Impact factor: 1.059

8.  Carotid disease and retinal optical coherence tomography angiography parameters in patients with non-arteritic anterior ischemic optic neuropathy.

Authors:  Fatma Selin Kaya
Journal:  Int Ophthalmol       Date:  2021-08-18       Impact factor: 2.031

9.  Diffusion MR imaging in a case of acute ischemic optic neuropathy.

Authors:  L S Al-Shafai; D J Mikulis
Journal:  AJNR Am J Neuroradiol       Date:  2006-02       Impact factor: 3.825

10.  Could Platelet Indices and Neutrophil to Lymphocyte Ratio Be New Biomarkers for Differentiation of Arteritic Anterior Ischemic Neuropathy from Non-Arteritic Type?

Authors:  Merve Inanc; Kemal Tekin; Ozlem Budakoglu; Bayazit Ilhan; Onder Aydemir; Pelin Yilmazbas
Journal:  Neuroophthalmology       Date:  2018-01-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.